| AE | Adverse effects |
| BoNT | Botulinum toxin |
| CSM | Corrugator supercilia muscle |
| DAO | Depressor anguli oris |
| DLI | Depressor labii inferioris |
| FM | Frontalis muscle |
| HAS | Human Serum Albumin |
| IM | Intramuscularly |
| U | International Unit |
| IV | Intravenously |
| L | Liquid |
| LLS | Levator labii superioris |
| LLSAN | Levator labii superioris alaeque nasi |
| NACL | Sodium chloride |
| NAPs | Neurotoxin-associated complexing proteins |
| OOc | Orbicularis oculi |
| OOr | Orbicularis oris |
| P | Powder |
| PO | Orally |
| q.s. | Quantum sufficit |
| US | Ultrasonography |
| Zmi | Zygomaticus minor |
| ZMj | Zygomaticus major |
| IP | Injection points |
| n | Number |
| F | Female |
| M | Male |
| Up | Upper |
| L | Lower |
| NR | Not reported |